New Revelations Show Unusual Conditions At Now-Banned Sun India Plant
This article was originally published in PharmAsia News
Executive Summary
Newly reported information from a report shows an inspection by the U.S. FDA of a Sun Pharmaceutical Industries production plant in India did not find just run-of-the-mill violations, it found chaotic conditions.
Newly reported information from a report shows an inspection by the U.S. FDA of a Sun Pharmaceutical Industries production plant in India did not find just run-of-the-mill violations, it found chaotic conditions. The report said inspectors encountered feces on the walls, a strong urine smell, rat traps, stacked garbage and bathrooms in disrepair. The plant subsequently was banned from exporting drugs to the U.S. Sun responded that since learning about the conditions, it has resolved to work on strengthening its systems and controls. (Click here for more
)
"FDA Banned Sun Plant After Finding Data Flaws, Rat Traps" - Bloomberg (U.S.) (4/24/2014)